A triplet combination with capecitabine/oxaliplatin/irinotecan (XELOXIRI) plus cetuximab as first-line therapy for patients with metastatic colorectal cancer: a dose escalation study

被引：0
作者：
Yasushi Sato
Masahiro Hirakawa
Hiroyuki Ohnuma
Minoru Takahashi
Tetsuro Okamoto
Koichi Okamoto
Hiroshi Miyamoto
Naoki Muguruma
Tomohisa Furuhata
Ichiro Takemasa
Junji Kato
Tetsuji Takayama
机构：
[1] Tokushima University Graduate School of Biomedical Sciences,Department of Community Medicine for Gastroenterology and Oncology
[2] Sapporo Medical University School of Medicine,Department of Medical Oncology
[3] Sapporo Kyoritsu Gorinbashi Hospital,Division of Gastroenterology
[4] Kiyota Hospital,Division of Gastroenterology
[5] Tokushima University Graduate School of Biomedical Sciences,Department of Gastroenterology and Oncology
[6] St. Marianna Medical University Toyoko Hospital,Department of Gastroenterological Surgery
[7] Sapporo Medical University School of Medicine,Department of Surgery, Surgical Oncology and Science
来源：
Cancer Chemotherapy and Pharmacology | 2017年 / 80卷
关键词：
Colorectal cancer; Capecitabine; Irinotecan; Oxaliplatin; Cetuximab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1133 / 1139
页数：6
相关论文
共 86 条
[61]  
Ohnuma H(undefined)undefined undefined undefined undefined-undefined
[62]  
Hirakawa M(undefined)undefined undefined undefined undefined-undefined
[63]  
Maughan TS(undefined)undefined undefined undefined undefined-undefined
[64]  
Adams RA(undefined)undefined undefined undefined undefined-undefined
[65]  
Smith CG(undefined)undefined undefined undefined undefined-undefined
[66]  
Adams RA(undefined)undefined undefined undefined undefined-undefined
[67]  
Meade AM(undefined)undefined undefined undefined undefined-undefined
[68]  
Madi A(undefined)undefined undefined undefined undefined-undefined
[69]  
Minami H(undefined)undefined undefined undefined undefined-undefined
[70]  
Sai K(undefined)undefined undefined undefined undefined-undefined
123456789